Lipid-based nanoparticles (LNPs) are nanoscale carriers composed of lipids that are used to deliver therapeutic agents, such as drugs or genetic materials, directly to target cells. These nanoparticles are particularly useful in the field of cancer treatment due to their ability to encapsulate various types of therapeutic agents, improve drug solubility, enhance cellular uptake, and reduce systemic toxicity.
